AstraZeneca Commits $2.5 Billion to Launch Cutting-Edge R&D Hub in Beijing

AstraZeneca announces a $2.5 billion investment to establish a strategic R&D center in Beijing, marking its second in China and sixth worldwide. This move highlights the company's ...